Search
+
    SEARCHED FOR:

    NITIN RAHEJA

    Commodity Talk| Equities, bonds... and commodities? Why investors may need a third pillar for diversification, Navneet Damani decodes

    Once seen largely as a cyclical trading opportunity or an inflation hedge, commodities are increasingly finding a place in long-term portfolio allocation. From gold's role as a hedge against currency and geopolitical risks to copper's structural demand story driven by electrification, AI and data centres, the investment case is evolving.

    Why DSP Mutual Fund's Chirag Dagli is betting on CDMO, hospitals and smallcap healthcare stocks

    At the same time, the fund is evaluating hospital expansion, hybrid diagnostics businesses and valuations to identify healthcare companies capable of sustaining growth.

    ETMarkets Smart Talk | India could start looking attractive on FY28 earnings in six months: Nitin Raheja, Julius Baer India

    While the Nifty 50 is currently trading around its long-term historical averages, sustained earnings growth and continued domestic inflows could make the market increasingly attractive from a forward-looking perspective.

    Time to tilt towards largecaps; 3 sectors to get into on correction: Nitin Raheja

    Nitin Raheja advises largecaps amid corrections in mid and smallcaps. Financials face challenges, chemical companies show resilience. Birla Group unlocking value. Caution on FMCG and battery stocks. Pharma presents defensive play with growth potential.

    Can there be value buying in HDFC Bank? Should one go for upstream oil cos? Nitin Raheja answers

    Nitin Raheja discusses challenges faced by OMCs, the pressure on HDFC Bank, re-rating of defence stocks, performance of upstream oil companies, and the positive outlook for the pharma sector. Coming to HDFC Bank, he says we are getting to that stage where there is clearly value sitting there. It is only a question of when you start seeing the flow ease off and I think that will happen sooner than later.

    Prefer private banking, midcap IT, pharma stocks: Nitin Raheja

    When I look across sectors, I find some values happening in spaces like midcap pharma and IT; I also prefer private sector banks, says Raheja.

    The Economic Times
    BACK TO TOP